Sign in to confirm you’re not a bot
This helps protect our community. Learn more

MigVax: Why OurCrowd is investing in Israel's Covid-19 oral vaccine

OurCrowd
5.25K subscribers
<__slot-el>
<__slot-el>
913 views 4 years ago
Jon Medved, CEO of OurCrowd, explains why OurCrowd is investing in MigVax, established by the MIGAL Galilee Research Institute for the purpose of completing development and commercialization of an oral coronavirus vaccine. More details: https://www.ourcrowd.com/companies/mi... More from OurCrowd: https://www.ourcrowd.com/ ...more
...more
MigVax: Why OurCrowd is investing in Israel's Covid-19 oral vaccine
18Likes
913Views
2020Dec 3
Jon Medved, CEO of OurCrowd, explains why OurCrowd is investing in MigVax, established by the MIGAL Galilee Research Institute for the purpose of completing development and commercialization of an oral coronavirus vaccine. More details: https://www.ourcrowd.com/companies/mi... More from OurCrowd: https://www.ourcrowd.com/

Follow along using the transcript.

OurCrowd

5.25K subscribers